Led Alloy Therapeutics' $40M Series E to scale tech-enabled biotech infrastructure.
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. They collaborate with over 170 partners, including Fortune 50 Biopharmaceutical companies, to enable the discovery of breakthrough biologic medicines through their antibody and bispecific discovery platforms, T cell receptor modalities, and novel RNA therapeutics.